Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
Why Is CDW Corporation (CDW) Stock Down -15.22% Today?

Why Is CDW Corporation (CDW) Stock Down -15.22% Today?

Key Takeaways

  • CDW shares plunged 15.22% in Wednesday's trading session after the IT solutions provider reported second-quarter 2026 earnings that beat on revenue and EPS but missed significantly on gross margins.
  • Gross margin contracted to 20.1% (versus 21.2% expected), dragged lower by a product mix shift toward lower-margin hardware categories including servers, storage, and networking equipment.
  • CFO Albert Miralles announced his retirement (effective 2027 upon successor appointment), introducing an additional layer of leadership uncertainty that compounded the negative reaction.
  • A sharp pre-earnings rally set the stage for a classic "sell-the-news" event, as traders locked in gains following a nearly 47% surge over the prior three months.
  • The selloff was entirely company-specific, with the S&P 500 and NASDAQ trading modestly higher on the day, confirming no broader macro headwinds were at play.
  • Traders are now watching for analyst revisions, the CFO succession plan, and whether CDW can deliver margin recovery in the second half of 2026.

Opening Summary

CDW Corporation, the Vernon Hills, Illinois-based IT solutions provider serving business, government, education, and healthcare customers, saw its stock tumble 15.22% on Wednesday after reporting second-quarter 2026 results. Shares fell from Tuesday's closing price of $154.00 to approximately $130.56 in mid-morning trading, erasing billions in market capitalization in a single session. The selloff came despite headline numbers that handily exceeded Wall Street expectations — net sales of $6.57 billion beat the $6.21 billion consensus, while adjusted earnings per share of $2.91 topped the $2.79 estimate. Instead, investors seized on contracting profit margins and a surprise CFO retirement announcement, transforming what appeared to be a strong quarter into one of the stock's worst single-day declines in recent memory.

Q2 Earnings: Revenue Beat Overshadowed by Margin Miss

The central catalyst behind Wednesday's plunge was CDW's second-quarter earnings report, released before the opening bell. On the surface, the numbers were robust: net sales climbed 10.0% year-over-year to $6.57 billion, powered by strong demand across data storage, servers, notebooks, software, and networking products. Adjusted EPS of $2.91 represented an 11.9% increase from the prior year's $2.60. Commercial segment revenue rose 9.2%, Government jumped 13.6%, and international operations surged 22.9%.

However, the quality of those earnings came under intense scrutiny. Gross profit margin contracted to 20.1%, down from 20.8% a year earlier and meaningfully below the 21.2% consensus estimate. Management attributed the compression to a product mix shift toward lower-margin hardware categories — a trend that, while boosting top-line growth, is steadily eroding profitability. Operating margin similarly deteriorated to 6.5% from 7.0%, while non-GAAP operating margin slipped to 8.5% from 8.7%. Selling and administrative expenses rose 8.6% to $891 million, driven by higher performance-based compensation and $44.2 million in workplace optimization costs related to workforce reductions and real estate consolidation. Net income rose just 1.2% to $274.4 million, underscoring how little of the double-digit revenue growth flowed to the bottom line.

CFO Retirement Adds Leadership Uncertainty

Compounding the margin concerns, CDW disclosed that Chief Financial Officer Albert Miralles plans to retire from the role in 2027, with the company launching a search for his successor. Miralles is a 35-year veteran of the firm who has served as CFO for five years, making him a deeply entrenched figure in CDW's financial stewardship. While the retirement is not immediate and the company emphasized an orderly transition, the announcement introduces an element of executive uncertainty at a sensitive juncture — just as investors are grappling with margin trajectory and competitive positioning. Leadership transitions in the CFO role are routinely met with investor caution, particularly when they coincide with an already disappointing earnings reaction.

Sell-the-News After Sharp Pre-Earnings Rally

Wednesday's selloff was amplified by the stock's own recent success. CDW shares had surged approximately 47% over the preceding three months and closed Tuesday at $154.00 — near the upper end of their 52-week range and dangerously close to the $173.38 high set a year earlier. The stock had gained 6.9% in the past week alone and 18.7% over two weeks, leaving it highly susceptible to profit-taking on any perceived disappointment. The pre-market reaction pointed to a decline of as much as 22.5% at its nadir, reflecting a market that had priced in near-perfection and was quick to punish anything less. This dynamic mirrors the stock's reaction to its first-quarter 2026 report, when shares also fell sharply on operating margin compression despite a revenue beat — a pattern that suggests investors are growing increasingly impatient with the disconnect between growing sales and stagnant profitability.

Market Context and Trading Activity

The selloff in CDW stood in stark contrast to broader equity markets, which traded modestly higher on Wednesday — the S&P 500 rose approximately 0.4% and the NASDAQ added roughly 0.2%. This divergence confirmed that the move was entirely company-specific rather than driven by macroeconomic headwinds. Trading volume surged well above the daily average of roughly 1.7 million shares, reflecting intense institutional repositioning. Within the IT distribution space, peers such as TD SYNNEX and Connection had already reported strong second-quarter results — TD SYNNEX posted 31% year-over-year revenue growth — setting a high bar that made CDW's margin erosion comparatively more glaring. The stock sliced through several technical levels in the decline, retreating from near the top of its 52-week range toward levels not seen since mid-July.

What Comes Next for CDW

Looking ahead, CDW management reiterated confidence in the company's ability to exceed U.S. IT addressable market growth by 200 to 300 basis points on a constant currency basis, but did not provide a formal quantified guidance update — a omission that left analysts and investors with limited forward visibility. The company's diversified customer base across commercial, government, education, and international segments provides multiple growth levers, and its $1 billion share repurchase authorization announced in May signals management's conviction in long-term value. However, persistent margin compression, an uncertain CFO succession timeline, and the potential for further analyst downgrades represent tangible near-term risks. The next major catalyst will be the third-quarter 2026 earnings report, expected in November, where investors will be watching closely for evidence of operating leverage returning to the business and for further details on the CFO transition plan.

Trending AI Robots

For investors seeking systematic approaches to navigating volatile markets, Tickeron's Trending AI Robots page offers a curated view of hundreds of AI-powered trading bots covering thousands of tickers — including CDW. These bots vary by strategy, timeframe, performance metrics, and traded symbols, but only the strongest performers under current market conditions are featured in this dynamic selection. Traders can explore bot-driven signals to complement their own research process and stay ahead of fast-moving market developments like today's earnings-driven selloff.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CDW

CDW sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for CDW moved above the 200-day moving average on July 31, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on CDW as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CDW just turned positive on July 28, 2026. Looking at past instances where CDW's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDW advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 226 cases where CDW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CDW broke above its upper Bollinger Band on June 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.704) is normal, around the industry mean (7.820). P/E Ratio (18.770) is within average values for comparable stocks, (71.183). CDW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.103). Dividend Yield (0.016) settles around the average of (0.025) among similar stocks. P/S Ratio (0.882) is also within normal values, averaging (148.701).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CDW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.42B. The market cap for tickers in the group ranges from 0 to 221.54B. IBM holds the highest valuation in this group at 221.54B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 9%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 57%. CYCU experienced the highest price growth at 177%, while DAIC experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 66
Price Growth Rating: 58
SMR Rating: 72
Profit Risk Rating: 93
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
CDW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of information technology solutions

Industry InformationTechnologyServices

Profile
Details
Industry
Information Technology Services
Address
200 North Milwaukee Avenue
Phone
+1 847 465-6000
Employees
14800
Web
https://www.cdw.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.